TGF‐β Phospho Antibody Array Identifies Altered SMAD2, PI3K/AKT/SMAD and RAC Signalling Contribute to the Pathogenesis of Myxomatous Mitral Valve Disease

Biochemistry, Genetics and Molecular Biology

• Small Interfering RNA 100%
• ACTA2 100%
• SMAD 100%
• Agonist 100%
• Myofibroblast 100%
• Protein Kinase B 100%
• Marker Gene 100%
• Signaling Protein 50%
• Mammalian Target of Rapamycin 50%
• Reverse Transcription Polymerase Chain Reaction 50%
• Transcription Factors 50%
• Protein Expression 50%
• Immunoblotting 50%
• RNAI 50%
• PI3K/AKT/mTOR Pathway 50%

Veterinary Science and Veterinary Medicine

• Myxomatous Mitral Valve Disease 100%
• Dog 40%
• Myofibroblast 40%
• Transcription Factors 20%
• Reverse Transcription Polymerase Chain Reaction 20%